Anixa Biosciences Inc. (NASDAQ:ANIX) shares surged 15.21% in after-hours trading on Thursday, reaching $5.53, after the company presented final Phase 1 clinical trial data for its investigational breast cancer vaccine.Check out the current price of ANIX stock here.Phase 1 Trial ResultsThe healthcare company presented final data Thursday at the 2025 San Antonio Breast Cancer Symposium. The trial, conducted with the Cleveland Clinic and funded by a U.S. Department of Defense grant, showed the vaccine met all ...